Current Report Filing (8-k)

Date : 08/10/2018 @ 2:02PM
Source : Edgar (US Regulatory)
Stock : Plx Pharma Inc. (PLXP)
Quote : 3.82  -0.02 (-0.52%) @ 2:34PM
PLx Pharma Inc. share price Chart

Current Report Filing (8-k)



Washington, D.C. 20549





Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of Earliest Event Reported): August 10, 2018


PLx Pharma Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-36351 46-4995704
(State or Other Jurisdiction
of Incorporation)
File Number)
(IRS Employer
Identification No.)
8285 El Rio Street, Ste. 130, Houston, Texas 77054
(Address of Principal Executive Offices) (Zip Code)


Registrant’s Telephone Number, Including Area Code: (713) 842-1249


(Former Name or Former Address, If Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 



Item 7.01Regulation FD Disclosure.


Pursuant to Regulation FD, PLx Pharma Inc. (the “Company”) hereby furnishes the Corporate Presentation that Natasha Giordano, the President and Chief Executive Officer of the Company, will present to investors on or after August 10, 2018. The Corporate Presentation is attached hereto as Exhibit 99.1 and will be available on the Company’s website under the Investor Relations tab.


The information furnished by the Company pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise subject to the liability of that section, and shall not be deemed to be incorporated by reference into any Company filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. 


Item 9.01Financial Statements and Exhibits.



 Exhibit No.Description
99.1PLx Pharma Inc. August 2018 Corporate Presentation.






Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Dated: August 10, 2018 By: /s/ Natasha Giordano  
    Name: Natasha Giordano  
    Title: President and Chief Executive Officer  




This regulatory filing also includes additional resources:

PLx Pharma Inc. (NASDAQ:PLXP)
Historical Stock Chart

1 Year : From Dec 2017 to Dec 2018

Click Here for more PLx Pharma Inc. Charts.

PLx Pharma Inc. (NASDAQ:PLXP)
Intraday Stock Chart

Today : Friday 14 December 2018

Click Here for more PLx Pharma Inc. Charts.

Latest PLXP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20181214 15:02:32